Genomic alterations predictive of poor clinical outcomes in pan-cancer.

Seldon, Crystal S; Meiyappan, Karthik; Hoffman, Hannah; Guo, Jimmy A; Goel, Neha; Hwang, William L; Nguyen, Paul L; Mahal, Brandon A; Alshalalfa, Mohammed

Seldon, Crystal S; Meiyappan, Karthik; Hoffman, Hannah; Guo, Jimmy A; Goel, Neha; Hwang, William L; Nguyen, Paul L; Mahal, Brandon A; Alshalalfa, Mohammed.

Afiliação

Seldon CS; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
Meiyappan K; Co-first authors.
Hoffman H; Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Guo JA; Co-first authors.
Goel N; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.
Hwang WL; Broad Institute of MIT, Cambridge, MA 02142, USA.
Nguyen PL; School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Mahal BA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
Alshalalfa M; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

Oncotarget ; 13: 1069-1077, 2022.

Article em En | MEDLINE | ID: mdl-36187555

Assuntos

Neoplasias; Variações do Número de Cópias de DNA; Genômica; Humanos; Mutação; Neoplasias/genética; Prognóstico

Palavras-chave

TCGA; TP53; genomic alterations; poor prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google